Radezolid
- Generic Name
- Radezolid
- Drug Type
- Small Molecule
- Chemical Formula
- C22H23FN6O3
- CAS Number
- 869884-78-6
- Unique Ingredient Identifier
- 53PC6LO35W
- Background
Radezolid has been used in trials studying the treatment of Abscess, Bacterial Skin Diseases, Streptococcal Infections, Infectious Skin Diseases, and Staphylococcal Skin Infections, among others.
Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
Phase 2
Completed
- Conditions
- Infectious Skin DiseasesBacterial Skin DiseasesStaphylococcal Skin InfectionsStreptococcal InfectionsAbscess
- Interventions
- First Posted Date
- 2008-03-31
- Last Posted Date
- 2014-03-27
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT00646958
- Locations
- 🇺🇸
Jamaica Hospital Medical Center, Jamaica, New York, United States
🇺🇸Mercury Street Medical Group, LLC, Butte, Montana, United States
🇺🇸Healthcare Partners Medical Group, Los Angeles, California, United States
Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 158
- Registration Number
- NCT00640926
- Locations
- 🇨🇦
Westview Research, North Vancouver, British Columbia, Canada
🇺🇸Mercury Street Medical Group, LLC, Butte, Montana, United States
🇨🇦Ronald Collette, MD, Burnaby, British Columbia, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath